AFYA · NASDAQ · Education & Training Services

Afya (AFYA)

Connects Brazilian physicians to education, clinical content and practice solutions.

$13.61
vs last close+0.06 (+0.45%)
Loading prices…

Afya LimitedAFYA
Consumer Discretionary

Provides medical-school education, residency preparation, continuing education, clinical content and practice solutions in Brazil. Its acquisition-led model expands the medical-school footprint and depends on approvals for medical-school seats.

Combines undergraduate medical education with residency-test preparation, continuing medical education, clinical content and technology, and digital tools for medical practice. The end-to-end model follows physicians from medical school through practice at each career stage, anchored in a Brazilian network whose roots reach back to 1999.

Acquisitions are central to expanding the medical-school footprint, with recent additions including DelRey, Unidom and FUNIC. The business depends on approvals for medical-school seats and is exposed to regulatory, legal, data-protection and cybersecurity requirements. Unidom seat authorizations remained subject to a final court conclusion at year-end.

Company facts

CEOVirgilio Deloy Capobianco Gibbon
ListedJul 19, 2019
ExchangeNASDAQ
HeadquartersBelo Horizonte, Brazil
CountryBrazil
Employees9,395
CIK0001771007
ISINKYG011251066

Market cap$1.22B
EPS (ttm)$1.70
P/E (ttm)7.97
ROE16.4%
P/B1.28
P/S1.62
Dividend yieldDiv yield4.84%
Beta0.36vs XLY 0.29

Price target$16.50+21.8%Average of 8 analysts
ConsensusHold4 of 8 analysts
Ratings

Target rangeAs of Sep 21, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Feb 24, 2026B of A SecuritiesDowngrade
Rating: Buy
Rating: Neutral
Feb 13, 2026Morgan StanleyDowngrade
Rating: Equal WeightTarget: $17.50
Rating: UnderweightTarget: $16
Jan 21, 2026BTG PactualTarget
Target:
Target: $17
Jan 16, 2026UBSDowngrade
Rating: BuyTarget: $18
Rating: NeutralTarget: $16
Jan 8, 2026UBSReiterate
Rating: Target: $19
Rating: BuyTarget: $18

Next report
Nov 12, 26
in 51 days
EPS estimate
$0.38
Revenue estimate
$196.3M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$0.36$0.55$0.40$0.38$0.41$0.56$0.45Pending
Estimate$0.34$0.46$0.40$0.32$0.38$0.53$0.39$0.38
Surprise+5.9%+19.6%0.0%+18.8%+7.9%+5.7%+15.7%

RevenueReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$136.9M$160.3M$169.3M$174.0M$166.3M$192.7M$187.4MPending
Estimate$160.5M$165.5M$173.0M$174.5M$167.6M$204.5M$189.6M$196.3M
Surprise−14.7%−3.1%−2.2%−0.3%−0.8%−5.8%−1.2%
Estimate$0.38
ReportedDue Nov 12, 2026
Estimate$196.3M
ReportedDue Nov 12, 2026
View details

Debt to equity63.80%
Current ratio220.10%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$164.4M$166.0M$183.0M$179.7M$181.5M$181.2M$194.3M$194.3M
Net income$23.5M$29.3M$49.3M$33.7M$30.3M$34.3M$49.3M$39.4M
Net margin14.3%17.7%26.9%18.7%16.7%18.9%25.4%20.3%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income$45.7M$50.4M$72.8M$55.8M$54.2M$54.1M$75.3M$58.4M
YoY growth+22.9%+51.3%+28.7%+23.6%+18.6%+7.3%+3.4%+4.7%

Balance sheet, Jun 30, 2026Cash & short-term investments $196.5M · Total debt $608.6M · Total assets $1.82B · Shareholders' equity $954.2M

Revenue
$194.3M
Operating income
$58.4M
Net income
$39.4M

Reported in BRL, converted at the latest exchange rate

View details

Dividend yield
4.84%
Next ex-date
Mar 25, 27
estimated · in 184 days
Annual dividend
$0.66
per share
Schedule
Annual
one payment a year

HistoryDividendAnnual yield

Mar '26
Dividend$0.6565
Annual yield4.33%
Ex-dateMar 25
Payment dateApr 6
View details

Institutions12.03%10.86M ADS
55 holders · as of Jun 30, 2026
Insiders69.50%62.72M ADS
16 holders · as of Jun 30, 2026
Strategic holders4.71%4.25M ADS
2 holders · as of Feb 14, 2022
Other13.76%12.41M ADS
remainder

90.25M ADS as of Aug 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

The share count is from the company's Dec 2024 annual report; nothing newer is on file here.

This company has 2 share classes; every stake here is a share of the whole company.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
Educacional II Fundo de Investimento em Participações MultiestratégiaInsider
27.62%24.93Mfiled Feb 14, 2020
MultiestratégiaInsider
26.86%24.24Mfiled Feb 10, 2021
Nicolau Carvalho EstevesInsiderdirector
5.91%5.34M A ordinaryfiled Mar 23, 2026
Financial, Inc.Strategic
3.06%2.76Mfiled Feb 14, 2022
FMR LLCInstitution
2.90%2.61M A ADSas of Jun 30, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Jul 1, 2026Lelio de Souza Juniorofficer: Vice President−36,204$15.00
Jun 26, 2026Lelio de Souza Juniorofficer: Vice President−41,541$15.00
Jun 26, 2026Gomiero Mirella Basolliofficer: Vice President−10,000$14.80
Apr 17, 2026Santos Welder Ferreiraofficer: Controller−3,325$15.90
Apr 13, 2026De Sousa Anibal Jose Grifoofficer: VP Legal, Comp., & Gov Rel.−14,000$15.41
View details

Not reported.